Logo image of PHLT

PERFORMANT HEALTHCARE INC (PHLT) Stock Fundamental Analysis

NASDAQ:PHLT - Nasdaq - US71377E1055 - Common Stock - Currency: USD

2.49  +0.05 (+2.05%)

After market: 2.49 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to PHLT. PHLT was compared to 106 industry peers in the Health Care Providers & Services industry. While PHLT seems to be doing ok healthwise, there are quite some concerns on its profitability. PHLT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

PHLT had negative earnings in the past year.
PHLT had a positive operating cash flow in the past year.
PHLT had negative earnings in each of the past 5 years.
Of the past 5 years PHLT 4 years had a positive operating cash flow.
PHLT Yearly Net Income VS EBIT VS OCF VS FCFPHLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

With a Return On Assets value of -9.72%, PHLT is not doing good in the industry: 72.64% of the companies in the same industry are doing better.
PHLT has a Return On Equity of -12.93%. This is in the lower half of the industry: PHLT underperforms 61.32% of its industry peers.
Industry RankSector Rank
ROA -9.72%
ROE -12.93%
ROIC N/A
ROA(3y)-7.6%
ROA(5y)-8.46%
ROE(3y)-9.98%
ROE(5y)-15.16%
ROIC(3y)N/A
ROIC(5y)N/A
PHLT Yearly ROA, ROE, ROICPHLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PHLT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PHLT Yearly Profit, Operating, Gross MarginsPHLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

More info and screens

6

2. Health

2.1 Basic Checks

PHLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
PHLT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, PHLT has more shares outstanding
The debt/assets ratio for PHLT is higher compared to a year ago.
PHLT Yearly Shares OutstandingPHLT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
PHLT Yearly Total Debt VS Total AssetsPHLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 4.80 indicates that PHLT is not in any danger for bankruptcy at the moment.
PHLT has a Altman-Z score of 4.80. This is amongst the best in the industry. PHLT outperforms 83.02% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that PHLT is not too dependend on debt financing.
PHLT's Debt to Equity ratio of 0.10 is fine compared to the rest of the industry. PHLT outperforms 72.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 4.8
ROIC/WACCN/A
WACC8.95%
PHLT Yearly LT Debt VS Equity VS FCFPHLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 2.75 indicates that PHLT has no problem at all paying its short term obligations.
PHLT has a better Current ratio (2.75) than 82.08% of its industry peers.
PHLT has a Quick Ratio of 2.75. This indicates that PHLT is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of PHLT (2.75) is better than 83.02% of its industry peers.
Industry RankSector Rank
Current Ratio 2.75
Quick Ratio 2.75
PHLT Yearly Current Assets VS Current LiabilitesPHLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

PHLT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -30.00%.
The Revenue has grown by 8.12% in the past year. This is quite good.
PHLT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.95% yearly.
EPS 1Y (TTM)-30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-150%
Revenue 1Y (TTM)8.12%
Revenue growth 3Y-0.38%
Revenue growth 5Y-3.95%
Sales Q2Q%6.75%

3.2 Future

PHLT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 70.36% yearly.
PHLT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.14% yearly.
EPS Next Y100%
EPS Next 2Y70.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.43%
Revenue Next 2Y10.14%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PHLT Yearly Revenue VS EstimatesPHLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
PHLT Yearly EPS VS EstimatesPHLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2021 2022 2023 2024 2026 0 0.2 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PHLT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PHLT Price Earnings VS Forward Price EarningsPHLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PHLT Per share dataPHLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PHLT's earnings are expected to grow with 70.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y70.36%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PHLT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PERFORMANT HEALTHCARE INC

NASDAQ:PHLT (4/17/2025, 8:00:00 PM)

After market: 2.49 0 (0%)

2.49

+0.05 (+2.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-12 2025-03-12/amc
Earnings (Next)05-13 2025-05-13/amc
Inst Owners80.9%
Inst Owner ChangeN/A
Ins Owners5.34%
Ins Owner ChangeN/A
Market Cap194.99M
Analysts82.22
Price Target7.14 (186.75%)
Short Float %1.46%
Short Ratio6.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.57%
Min EPS beat(2)1.96%
Max EPS beat(2)41.19%
EPS beat(4)4
Avg EPS beat(4)22.33%
Min EPS beat(4)1.96%
Max EPS beat(4)41.19%
EPS beat(8)7
Avg EPS beat(8)54.41%
EPS beat(12)11
Avg EPS beat(12)56.95%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.19%
Min Revenue beat(2)-2.19%
Max Revenue beat(2)-0.18%
Revenue beat(4)2
Avg Revenue beat(4)0.88%
Min Revenue beat(4)-2.19%
Max Revenue beat(4)3.71%
Revenue beat(8)4
Avg Revenue beat(8)-0.12%
Revenue beat(12)7
Avg Revenue beat(12)1.19%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)42.85%
EPS NQ rev (3m)42.85%
EPS NY rev (1m)100%
EPS NY rev (3m)100%
Revenue NQ rev (1m)0.26%
Revenue NQ rev (3m)2.66%
Revenue NY rev (1m)-1.34%
Revenue NY rev (3m)-1.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.59
P/FCF N/A
P/OCF 31.56
P/B 2.55
P/tB 6.69
EV/EBITDA N/A
EPS(TTM)-0.13
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.08
OCFY3.17%
SpS1.57
BVpS0.98
TBVpS0.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.72%
ROE -12.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-7.6%
ROA(5y)-8.46%
ROE(3y)-9.98%
ROE(5y)-15.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.21
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 106.24%
Cap/Sales 5.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.75
Quick Ratio 2.75
Altman-Z 4.8
F-Score3
WACC8.95%
ROIC/WACCN/A
Cap/Depr(3y)88.51%
Cap/Depr(5y)80.81%
Cap/Sales(3y)4.21%
Cap/Sales(5y)3.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-150%
EPS Next Y100%
EPS Next 2Y70.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.12%
Revenue growth 3Y-0.38%
Revenue growth 5Y-3.95%
Sales Q2Q%6.75%
Revenue Next Year8.43%
Revenue Next 2Y10.14%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-52.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year185.03%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-193.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y60.05%
OCF growth 3Y88.66%
OCF growth 5YN/A